Aesthetics & botox stocks
미용·보톡스
What are Aesthetics & botox stocks in Korea?
The Aesthetics & botox theme on jonbur groups 25 Korean stocks listed on KOSPI and KOSDAQ, worth ₩22T in total. On Oct 30, 2026 the group moved down 4.64% (weighted by market value); the largest members are APR, Hugel, PharmaResearch.
Key facts
- Stocks
- 25
- Total market value
- ₩22T
- Day's move
- −4.64%
- As of
- Oct 30, 2026
- Largest members
- APR, Hugel, PharmaResearch
Earnings tracker · 3Q 2026
Reporting season · reports due by Nov 14
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| APR | Oct 30Preliminary | ₩773B | +100.3% | ₩161B | +67.1% | +319.6% | 20.8%24.9% |
| Metacare | Oct 26Preliminary | ₩567M | −94.7% | −₩229M | Turned to loss | Turned to loss | −40.4%1.1% |
| Shaperon | Oct 1Preliminary | ₩4.7B | +2,683.4% | — | — | — | — |
| Dong-A Pharmaceutical | Expected around Oct 29 | ||||||
| Hyundai Bioland | Expected around Nov 3 | ||||||
| Hugel | Expected around Nov 4 | ||||||
| Daewoong Pharma | Expected around Nov 7 | ||||||
| Interojo | Expected around Nov 7 | ||||||
| Classys | Expected around Nov 10 | ||||||
| Medy-Tox | Expected around Nov 10 | ||||||
| PharmaResearch | Expected around Nov 11 | ||||||
| WON Tech | Expected around Nov 12 | ||||||
| Kangstem Biotech | Expected around Nov 13 | ||||||
| ELC | Expected around Nov 13 | ||||||
| Caregen | Expected around Nov 14 | ||||||
| L&C Bio | Expected around Nov 14 | ||||||
| Humedix | Expected around Nov 14 | ||||||
| Jetema | Expected around Nov 14 | ||||||
| Hironic | Expected around Nov 14 | ||||||
| P&K Skin Research Center | Expected around Nov 14 | ||||||
| Carelabs | Expected around Nov 14 | ||||||
| RollingStone | Expected around Nov 14 | ||||||
| RecensMedical | Not yet | ||||||
| Medyssey | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| 287410 | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Upcoming events
Korea events calendar →Technical breadth
After the close on Oct 30, 2026- Above 20-day average
- 4.5%
- Above 60-day average
- 9.1%
- RSI above 70
- 0%
- RSI below 30
- 18.2%
- 52-week highs
- 0
- 52-week lows
- 5
Index gauge · Short term
Bearish
0 bullish, 3 neutral, 6 bearish
Index gauge · Medium term
Bearish
0 bullish, 0 neutral, 8 bearish
Technical read
The Aesthetics & botox theme has 22 member stocks, and only 4.5% of them are trading above their 20-day averages while 9.1% are above their 60-day averages. No member is at a 52-week high, while 5 are at 52-week lows, and the lowest member RSI reads 18.2 with no members showing an RSI at the high extreme. The equal-weighted member index sits below its cloud with an RSI of 28.1, and both its short-term and medium-term gauges are labeled bearish.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 29, 202675Hyundai Department Store: ₩200bn of bonds due in the next 6 months vs ₩158bn cash₩200bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Hyundai Department StoreDaewonkangupHyundai G.F. HoldingsZinusHandsomeSamwonsteel
Aesthetics & botox
−5.32%미용·보톡스
The Aesthetics & Botox theme groups Korean listed companies that develop, manufacture, or distribute botulinum toxin injectables, dermal fillers, and other non-surgical cosmetic treatments, along with related medical aesthetic devices and clinic-linked businesses. Korean investors often cluster these firms together because the country has a large domestic and export market for such products, and many of them share similar regulatory approval processes, overseas licensing deals, and sales patterns tied to global cosmetic demand.
25 companies · 2 up · 2 flat · 21 down
- Traded value
- ₩354B
- Value vs 20-day average
- 1.83×
- Top gainer
- P&K Skin Research Center +6.53%
- Largest company
- APR ₩9.8T
Companies in this theme
| Company | Price | Weekly | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
APR278470 · KOSPI | ₩261,000 | −8.26% | ₩311B | ₩9.8T | 7.86% |
Daewoong Pharma069620 · KOSPI | ₩101,100 | −1.27% | ₩3.1B | ₩1.2T | 10.30% |
Dong-A Pharmaceutical000640 · KOSPI | ₩86,900 | −3.23% | ₩493M | ₩585B | 9.45% |
Source: KRX statistical information